Cited by 94Advanced Proteomics Techniques and ApplicationsBreast Cancer Treatment StudiesMass Spectrometry Techniques and Applications

Breast Cancer Classification Based on Proteotypes Obtained by SWATH Mass Spectrometry

Open access
Bouchal, Pavel, Schubert, Olga T., Faktor, Jakub, Capkova, Lenka, Imrichova, Hana, Zoufalova, Karolina, Paralova, Vendula, Hrstka, Roman +5 more·2019·Cell Reports

Published version of a preprint

Abstract

Accurate classification of breast tumors is vital for patient management decisions and enables more precise cancer treatment. Here, we present a quantitative proteotyping approach based on sequential windowed acquisition of all theoretical fragment ion spectra (SWATH) mass spectrometry and establish key proteins for breast tumor classification. The study is based on 96 tissue samples representing five conventional breast cancer subtypes. SWATH proteotype patterns largely recapitulate these subtypes; however, they also reveal varying heterogeneity within the conventional subtypes, with triple negative tumors being the most heterogeneous. Proteins that contribute most strongly to the proteotype-based classification include INPP4B, CDK1, and ERBB2 and are associated with estrogen receptor (ER) status, tumor grade status, and HER2 status. Although these three key proteins exhibit high levels of correlation with transcript levels (R > 0.67), general correlation did not exceed R = 0.29, indicating the value of protein-level measurements of disease-regulated genes. Overall, this study highlights how cancer tissue proteotyping can lead to more accurate patient stratification.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2019.06.046

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Bouchal, P., Schubert, O. T., Faktor, J., Capkova, L., Imrichova, H., Zoufalova, K., Paralova, V., Hrstka, R., Liu, Y., Ebhardt, H. A., Budinska, E., Nenutil, R., & Aebersold, R.
Affiliations
  • Masaryk University (CZ)
  • University of California, Los Angeles (US)
  • Masaryk Memorial Cancer Institute (CZ)
  • Yale University (US)
  • University College Dublin (IE)
  • University of Zurich (CH)
Corresponding author
  • Bouchal, Pavel
  • Aebersold, Ruedi
Venue
Cell Reports
Publisher
Elsevier BV
Published
2019-07
Volume
28
Issue
3
Pages
832-843.e7
ISSN
2211-1247 (ISSN-L)
OpenAlex
W2957606438
Cited by
94
References
5
Citations by year
2026: 5 · 2025: 4 · 2024: 11 · 2023: 14 · 2022: 17 · 2021: 20 · 2020: 19 · 2019: 4
FWCI
5.97
Type
journal article
Language
en
Open access
Locations
  • Cell Reports (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Lirias (submittedVersion, cc-by)
  • Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • ETH Zürich Research Collection (cc-by)
Funders
  • European Research Council (20140AdG 670821)
  • Ministerstvo Školství, Mládeže a Tělovýchovy (LO1413)
  • RECETOX Přírodovědecké Fakulty Masarykovy Univerzity (LM2015051)
  • Ministerstvo Zdravotnictví Ceské Republiky
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_166435)
  • Grantová Agentura České Republiky (17-05957S)
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
Keywords
breast cancer, proteotyping, SWATH mass spectrometry, breast cancer subtypes, triple-negative breast cancer, tumor heterogeneity, INPP4B, CDK1, ERBB2, estrogen receptor status, HER2 status, tumor grade, protein expression, transcript-protein correlation, patient stratification
MeSH terms
Breast Neoplasms, Female, Humans, Phosphoric Monoester Hydrolases, Receptors, Estrogen, CDC2 Protein Kinase, Erb-b2 Receptor Tyrosine Kinases, Receptor, ErbB-2, Proteome, Proteomics, Tandem Mass Spectrometry, High-Throughput Screening Assays

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review